Search Results - "E. Herrera-Ceballos"

A randomized, intraindividual, non‐inferiority, Phase III study comparing daylight photodynamic therapy with BF‐200 ALA gel and MAL cream for the treatment of actinic keratosis by Dirschka, T., Ekanayake‐Bohlig, S., Dominicus, R., Aschoff, R., Herrera‐Ceballos, E., Botella‐Estrada, R., Hunfeld, A., Kremser, M., Schmitz, B., Lübbert, H., Puig, S.

“…Background The most effective treatment modality for actinic keratosis (AK) is photodynamic therapy (PDT). Major obstacles of PDT are the need of a special…”
Get full text

Clinical, histological and immunohistochemical markers of resistance to methyl aminolaevulinate photodynamic therapy in Bowen disease by Gracia‐Cazaña, T., Salazar, N., Vera‐Álvarez, J., Aguilera, J., López‐Navarro, N., Herrera‐Ceballos, E., González, S., Juarranz, Á., Gilaberte, Y.

Get full text

Women with moderate‐to‐severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age‐adjusted fertility rate when compared with the general population by Gonzalez‐Cantero, A., Carretero, G., Rivera, R., Ferrándiz, C., Daudén, E., Cueva, P., Gómez‐García, F.J., Belinchón, I., Herrera‐Ceballos, E., Ruiz‐Genao, D., Ferrán, M., Alsina, M., Sánchez‐Carazo, J.L., Baniandrés, O., Sahuquillo‐Torralba, A., Rodriguez, L., Vilar, J., García, C., Carrascosa, J.M., Llamas‐Velasco, M., Herrera‐Acosta, E., López‐Estebaranz, J.L., Botella‐Estrada, R., Descalzo, M.A., García‐Doval, I.

Get full text

Time required for a standard sunscreen to become effective following application: a UV photography study by Gálvez, M.V., Aguilera, J., Buendía, E. A., Sánchez‐Roldán, C., Herrera‐Ceballos, E.

Get full text

Sun exposure and protection habits in transplant athletes: An international survey by Navarrete‐De Gálvez, M, Ruiz Sánchez, JM, Navarrete‐De Gálvez, E, Aguilera, J, Rivas‐Ruiz, F, Troya‐Martín, M, Herrera‐Ceballos, E, Gálvez, MV

“…Background Transplant recipients are particularly prone to the development of skin cancer, and overexposure to UV radiation during outdoor activities increases…”
Get full text

Is mitotic rate still useful in the management of patients with thin melanoma? by Tejera‐Vaquerizo, A., Pérez‐Cabello, G., Marínez‐Leborans, L., Gallego, E., Oliver‐Martínez, V., Martín‐Cuevas, P., Arias‐Santiago, S., Aneiros‐Fernández, J., Herrera‐Acosta, E., Traves, V., Herrera‐Ceballos, E., Nagore, E.

“…Background T1 melanoma substaging was recently modified by the American Joint Committee on Cancer (AJCC). Although sentinel lymph node (SLN) positivity is the…”
Get full text

Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry by Carretero, G., Ferrandiz, C., Dauden, E., Vanaclocha Sebastián, F., Gómez-García, F.J., Herrera-Ceballos, E., De la Cueva-Dobao, P., Belinchón, I., Sánchez-Carazo, J.L., Alsina-Gibert, M., López-Estebaranz, J.L., Ferrán, M., Torrado, R., Carrascosa, J.M., Carazo, C., Rivera, R., Jiménez-Puya, R., García-Doval, I.

“…Background Biobadaderm is the Spanish registry of psoriasis patients receiving systemic treatment in clinical practice. Objective To compare the safety of…”
Get full text

Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate‐to‐severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm by Belinchón, I., Ramos, J.M., Carretero, G., Ferrándiz, C., Rivera, R., Daudén, E., De la Cueva‐Dobao, P., Gómez‐García, F.J., Herrera‐Ceballos, E., Sánchez‐Carazo, J.L., López‐Estebaranz, J.L., Alsina, M., Ferrán, M., Torrado, R., Carrascosa, J.M., Llamas‐Velasco, M., Ortiz, P.L., García‐Doval, I., Descalzo, M.A.

“…Background Little is known about the adverse events (AEs) that lead to suspension of systemic treatments for psoriasis in clinical practice. Objective The…”
Get full text

Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry by Carrascosa, J.M., Vilavella, M., Garcia-Doval, I., Carretero, G., Vanaclocha, F., Daudén, E., Gómez-García, F.J., Herrera-Ceballos, E., De la Cueva Dobao, P., Belinchón, I., Sánchez-Carazo, J.L., Alsina, M., López-Estebaranz, J.L., Ferrán, M., Peral, F., Torrado, R., Rivera, R., Jiménez-Puya, R., Mendiola, M.V., Ferrándiz, C.

“…Background There are few data on the prevalence of obesity in the general psoriasis population and on the real impact of obesity on the management of psoriasis…”
Get full text

Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry by Medina, C., Carretero, G., Ferrandiz, C., Dauden, E., Vanaclocha, F., Gómez-García, F.J., Herrera-Ceballos, E., De la Cueva-Dobao, P., Belinchón, I., Sánchez-Carazo, J.L., Alsina, M., López-Estebaranz, J.L., Ferrán, M., Carrascosa, J.M., Torrado, R., Argila, D., Rivera, R., Jiménez-Puya, R., García-Doval, I.

“…Background Psoriasis patients over 65 years‐old (elderly) constitute a growing group, underrepresented in clinical trials, and likely to be more prone to…”
Get full text

Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort by Ruiz‐Genao, D., Perez‐Zafrilla, B., Lopez‐Estebaranz, J.L., Belinchón‐Romero, I., Carrascosa, J.M., Ferrán, M., Vanaclocha, F., Herrera‐Ceballos, E., García‐Doval, I.

Get full text

Mechanically-Induced Long-Period Fiber Gratings Using Laminated Plates by Torres-Gómez, Ismael, Ceballos-Herrera, Daniel E, Salas-Alcantara, Karla M

“…This work presents a formation method of mechanically-induced long-period fiber gratings using laminated plates. The mechanically-induced long-period fiber…”
Get full text

Growth rate as a prognostic factor in localized invasive cutaneous melanoma by Tejera-Vaquerizo, A, Barrera-Vigo, MV, López-Navarro, N, Herrera-Ceballos, E

“…Background  Melanoma is a tumour with a very variable progression. Whilst some melanomas grow slowly over many years, others can reach several millimetres in…”
Get full text

Demonstration of 108 Gb/s Duo-Binary PAM-8 Transmission and the Probabilistic Modeling of DB-PAM-M BER by Saber, Md Ghulam, Gutierrez-Castrejon, Ramon, Xing, Zhenping, Alam, Md Samiul, El-Fiky, Eslam, Ceballos-Herrera, Daniel E., Cavaliere, Fabio, Vall-Llosera, Gemma, Lessard, Stephane, Plant, David V.

“…We report 108 Gb/s Duo-Binary PAM-8 (DB-PAM-8) transmission using direct-detection aided by Volterra equalizer. The bit-error-rate (BER) performance of the…”
Get full text

Torsion Sensing Characteristics of Mechanically Induced Long-Period Holey Fiber Gratings by Ceballos-Herrera, D E, Torres-Gómez, I, Martínez-Ríos, A, García, Luis, Sánchez-Mondragón, J J

“…We present the spectral transmission response of a long-period holey fiber grating mechanically induced in two different twisted holey fibers. We have found…”
Get full text

Correlation of the growth rate of melanoma with the temporal appearance of metastasis by Tejera-Vaquerizo, A, Lopez-Navarro, N, Alcaide-Martin, A, Herrera-Acosta, E, Herrera-Ceballos, E

Get full text

Transverse Load and Temperature Sensing Using Multiplexed Long-Period Fiber Gratings by Torres-Gómez, Ismael, Martínez-Rios, Alejandro, Anzueto-Sánchez, Gilberto, Ceballos-Herrera, Daniel. E., Salceda-Delgado, Guillermo

“…The simultaneous measurement of transverse load and temperature using two long-period fiber gratings multiplexed in the wavelength domain is presented…”
Get full text

Thick melanoma: the problem continues by Tejera-Vaquerizo, A, Mendiola-Fernández, M, Fernández-Orland, A, Herrera-Ceballos, E

“…Background  The incidence of melanoma and its associated mortality has stabilized over the recent years, due in part to efforts directed at better prevention…”
Get full text

Unusual acquired dermal melanocytosis on the trunk by López Navarro, N., Fernandez Orland, A., Camacho Garrido, E., Bosch García, R. J., Herrera Ceballos, E.

Get full text

Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis by Dávila-Seijo, P., Dauden, E., Carretero, G., Ferrandiz, C., Vanaclocha, F., Gómez-García, F.-J., Herrera-Ceballos, E., De la Cueva-Dobao, P., Belinchón, I., Sánchez-Carazo, J.-L., Alsina, M., López-Estebaranz, J.-L., Ferrán, M., Torrado, R., Carrascosa, J.-M., Llamas, M., Rivera, R., Jiménez-Puya, R., García-Doval, I.

“…Background Few reported studies compare drug survival in moderate‐to‐severe psoriasis vulgaris. Objectives To describe and compare drug survival of systemic…”
Get full text